Geron Corporation's ( NASDAQ:GERN ) blood disorder drug, Imetelstat, has received a crucial vote of confidence from advisers to the U.S. Food and Drug Administration (FDA). Despite initial concerns raised by the agency's staff regarding data clarity and safety issues, the advisory panel overwhelmingly backed the benefits of Imetelstat for treating...
gern buy idea with stop shown in the graph we must keep the stop as shown in the graph
Setup: Rocketbase VCP: 5W 39/6 4T RS: 98 The posted chart contains a VCP (volatility contraction pattern). The first label "W" stands for weekly and shows the duration of the entire consolidation. In the middle label, the percentage of contractions is indicated (for example, "15/4"), with 15 representing the -15% depth of the base and 4 representing -4% of the...
short term resistance seen but the daily support is very good. so a bounce from daily support should take it to the 5$ mark
B or X Wave. Recovery within a recovery. This is a reflection using technical analysis + only and we do not consider valuation and macro factors at this stage. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels...
All, this chart sucks in all honestly, but think we are looking at a reversal here, needs to hold exact level it's at before moving up or may drop down one level bounce and should break out the top. Either way WW this week/next.
NASDAQ:GERN Possible Scenario: LONG Evidence: Price Action This is my idea and could be wrong 100% * It's a good buy opportunity right now, and it's ready to fly soon.
This one has a nice impulse up and it starting to look like it will continue that move. Once breaking out of the larger degree structure it looks like some positive buying is happening now.
New management, improvement in balance sheets convinced me. Sector is also outperforming. And now cup with handle pattern setup on chart. Looks like There is a strong resistance at current price, But I'm bullish. Target price = $4.5.
... for a 3.22 debit. Max Profit: $78/contract Max Loss/Buying Power Effect: $322 per contract Break Even/Cost Basis: 3.22/share Notes: A speculative shot on a high implied volatility biotech underlying ... .
9 year channel another attempt at breaking resistance If we can break resistance, price tgt: $10+
multiyear downtrend breaking here. broke up huge above recent highs on daily
Market retreats to 20 period EMA after making new highs (for long positions)/lows (for shorts) with ADX (14period) >30. Some people use the 20 period SMA. Projection is a retest of the highs. Trailing stop. Failed grails tend to move (painfully) in the opposite direction.
After the last few days of consolidation we find that GERN has broken its down trend with slight confirmation at a new uptrend. With that in mind the beginning of may should hold some value as data starts to surface and a shareholders meeting is set to take place around the 15th of May. This is a long-term play with a lot of upside potential. Looking for a strong...
Playing safe: buy stop order just above consolidation range. Break out catalyst: earnings report. Target as shown.